Cargando…
Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154939/ https://www.ncbi.nlm.nih.gov/pubmed/30249304 http://dx.doi.org/10.1186/s40880-018-0327-7 |
_version_ | 1783357792144326656 |
---|---|
author | Zhou, Lei Sheng, Dandan Deng, Qiaodan Wang, Dong Liu, Suling |
author_facet | Zhou, Lei Sheng, Dandan Deng, Qiaodan Wang, Dong Liu, Suling |
author_sort | Zhou, Lei |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6154939 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-61549392018-09-27 Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells Zhou, Lei Sheng, Dandan Deng, Qiaodan Wang, Dong Liu, Suling Cancer Commun (Lond) Letter to the Editor BioMed Central 2018-09-24 /pmc/articles/PMC6154939/ /pubmed/30249304 http://dx.doi.org/10.1186/s40880-018-0327-7 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Letter to the Editor Zhou, Lei Sheng, Dandan Deng, Qiaodan Wang, Dong Liu, Suling Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells |
title | Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells |
title_full | Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells |
title_fullStr | Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells |
title_full_unstemmed | Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells |
title_short | Development of a novel method for rapid cloning of shRNA vectors, which successfully knocked down CD44 in mesenchymal triple-negative breast cancer cells |
title_sort | development of a novel method for rapid cloning of shrna vectors, which successfully knocked down cd44 in mesenchymal triple-negative breast cancer cells |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154939/ https://www.ncbi.nlm.nih.gov/pubmed/30249304 http://dx.doi.org/10.1186/s40880-018-0327-7 |
work_keys_str_mv | AT zhoulei developmentofanovelmethodforrapidcloningofshrnavectorswhichsuccessfullyknockeddowncd44inmesenchymaltriplenegativebreastcancercells AT shengdandan developmentofanovelmethodforrapidcloningofshrnavectorswhichsuccessfullyknockeddowncd44inmesenchymaltriplenegativebreastcancercells AT dengqiaodan developmentofanovelmethodforrapidcloningofshrnavectorswhichsuccessfullyknockeddowncd44inmesenchymaltriplenegativebreastcancercells AT wangdong developmentofanovelmethodforrapidcloningofshrnavectorswhichsuccessfullyknockeddowncd44inmesenchymaltriplenegativebreastcancercells AT liusuling developmentofanovelmethodforrapidcloningofshrnavectorswhichsuccessfullyknockeddowncd44inmesenchymaltriplenegativebreastcancercells |